These repetitive sequences are so ubiquitous that they comprise approximately 50 % the genome in all dwelling mammals. "I just remember the extraordinary shock," says Samir Ounzain, a molecular biologist and chief government of a company named Haya Therapeutics, that's attempting to use our idea of